Kids First https://validator.w3.org/feed/docs/rss2.html Kids First: Congenital Heart Defects Kids First: Ewing Sarcoma – Genetic Risk Kids First: Orofacial Cleft – European Ancestry Kids First: Syndromic Cranial Dysinnervation Kids First: Adolescent Idiopathic Scoliosis Kids First: Disorders of Sex Development Kids First: Orofacial Cleft – Latin American Kids First: Neuroblastoma Kids First: Enchondromatoses Kids First: Familial Leukemia Kids First: Orofacial Cleft – African and Asian Ancestry Kids First: Novel Cancer Susceptibility in Families (from BASIC3) Kids First: Osteosarcoma Kids First: Craniofacial Microsomia Kids First: Kidney and Urinary Tract Defects Kids First: Microtia – Hispanic Kids First: Intersections of Cancer & SBD Kids First: Esophageal Atresia and Tracheoesophageal Fistulas Kid First: Hemangiomas (PHACE) Kids First: Nonsyndromic Craniosynostosis Kids First: Myeloid Malignancies Kids First: Leukemia & Heart Defects in Down Syndrome Kids First: T-Cell ALL Kids First: Cornelia de Lange Syndrome Kids First: Bladder extrophy, Epispadias, Complex Kids First: Laterality Birth Defects Kids First: CHARGE Syndrome Kids First: Orofacial Clefts – Philippines Kids First: Fetal Alcohol Spectrum Disorders Kids First: Intracranial Germ Cell Tumors Kids First: Structural Defects of The Neural Tube Kids First: Recessive Structural Brain Defects Kids First: Chromosome 18 Structural Birth Defects Children’s Brain Tumor Network (CBTN) Kids First: Whole genome sequencing studies of multiplex nonsyndromic cleft lip/palate families Publications The Gabriella Miller Kids First Data Resource for genomic research in pediatric cancer and congenital anomalies Home Kids First DRC Builds a Model for Continuous Discovery ASHG2026 Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia Germline Whole-Genome Sequencing in Early-Onset Pediatric Solid Tumors Implicates Novel Risk Factors A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease News